SEC Form 4 · accession 0001384101-18-000052
VERACYTE, INC. · VCYT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher M Hall
Officer — President and COO
Period of report
Jun 15, 2018
Accepted (ET)
Jun 19, 2018 · 6:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001384101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2018 | M | 10,509 | $0.80 | A | 42,964 | D | |
| Common StockF2,F3 | Jun 15, 2018 | S | 10,509 | $9.0003 | D | 32,455 | D | |
| Common Stock | Jun 19, 2018 | M | 9,491 | $0.80 | A | 41,946 | D | |
| Common StockF2,F4 | Jun 19, 2018 | S | 9,491 | $9.0486 | D | 32,455 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F5 | $0.80 | Jun 15, 2018 | M | 10,509 | D | — | Mar 30, 2020 | Common Stock | 10,509 | 69,491 | D |
| Stock Option (right to buy)F5 | $0.80 | Jun 19, 2018 | M | 9,491 | D | — | Mar 30, 2020 | Common Stock | 9,491 | 60,000 | D |
Explanation of responses
- F1The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 16, 2017.
- F2Represents the aggregate of sales effected on the same day at different prices.
- F3Represents weighted average sales price. Sale prices for the transactions range from $9.00 to $9.01. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- F4Represents weighted average sales price. Sale prices for the transactions range from $9.00 to $9.17. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- F5The option became exercisable as to 25% of the shares on March 15, 2011, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.